Top of this page
Skip navigation, go straight to the content

Newsroom Overview
 

Newsroom

image description
 

Press Release

Disposals of own shares20 Nov 2020

Disposals of own shares

Read more
UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in U.S. for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy17 Nov 2020

UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in …

Read more
UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms12 Nov 2020

UCB strengthens its gene therapy activities with additional pipeline programs …

Read more
 

UCB Stories

Picture of the globe 23 Nov 2020

Our commitment to innovative technology in Rare Disease

Read more
UCB unleashes the power of data in new collaboration 19 Nov 2020

UCB unleashes the power of data in new collaboration

Read more
Picture of lab items 12 Nov 2020

UCB strengthens its gene therapy activities

Read more

Social Media

 

Contact

The UCB media relations team responds to calls and emails from professional journalists only.